Evidence map›Paper›PMID 34195456›Full record

ArticleCurrent medical mycology2020

Optimization of the antifungal metabolite production in

Maryam Azish, Masoomeh Shams Ghahfarokhi, Mehdi Razzaghi Abyaneh

Open access · diamondAbstract read
In one paragraph

Article in Current medical mycology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. In vitro antifungal activity analysis of Streptomyces sp. strain 196 against Candida albicans and Aspergillus flavus.International microbiology : the official journal of the Spanish Society for Microbiology · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Maryam AzishDepartment of Mycology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Masoomeh Shams GhahfarokhiDepartment of Mycology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Mehdi Razzaghi AbyanehDepartment of Mycology, Pasteur Institute of Iran, Tehran, Iran.
Tarbiat Modares University · IRPasteur Institute of Iran · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeSoil bacteria have extreme population diversity among natural sources and are able to produce a wide array of antifungal metabolites. This study aimed to isolate and identify the bioactive metabolite-producing bacteria from forest soils and evaluate their antimicrobial potent against some pathogenic organisms. MATERIALS AND

methodsIn this study, soil samples were screened for antifungal activity against

resultsIn total, 110 bacterial strains were isolated from the forest soils and four species with high antifungal activity were identified as

conclusionBased on the results, forest soils contain organisms with antifungal activity and could be considered as a good source for novel antifungal metabolites as effective and safe therapeutics.

Indexed as

Antifungal metaboliteAspergillus spp.Soil bacteriaStreptomyces libani

Identifiers

PMID34195456
PMCPMC8226041
OpenAlexW3156911809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.